A PKA survival pathway inhibited by DPT-PKI, a new specific cell permeable PKA inhibitor, is induced by T. annulata in parasitized B-lymphocytes

Apoptosis

Volumn 11, Issue 8, 2006, Pages 1263-1273

  Guergnon, Julien ^a,f   Dessauge, Frederic ^a,e   Traincard, François ^b   Cayla, Xavier ^c   Rebollo, Angelita ^d   Bost, Pierre Etienne ^a   Langsley, Gordon ^b,g   Garcia, Alphonse ^a  

^a CNRS   (France)

^b INSTITUT PASTEUR   (France)

^c UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e CEMAGREF   (France)

^f UNIVERSITY OF VIRGINIA   (United States)

^g INSTITUT COCHIN   (France)

Author keywords

Apoptosis; Parasite; PKA: DPT PKI; Theileria

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; KT 5720; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE INHIBITOR;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL MEMBRANE PERMEABILITY; CELL PROTECTION; ENZYME ACTIVATION; ENZYME ACTIVITY; NONHUMAN; PARASITE SURVIVAL; PARASITOSIS; PHOSPHORYLATION; PRIORITY JOURNAL; THEILERIA ANNULATA;

BOS TAURUS; PROTOZOA;

EID: 33745853861     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-7702-6     Document Type: Article

References (37)

1. Chaussepied M, Langsley G (1996) Theileria transformation of bovine leukocytes: a parasite model for the study of lymphoproliferation. Res Immunol 147:127-138
2. Dobbelaere DA, Fernandez PC, Heussler VT (2000) Theileria parva: taking control of host cell proliferation and survival mechanisms. Cell Microbiol 2:91-99
3. Chaussepied M, Lallemand D, Moreau MF, Adamson R, Hall R, Langsley G (1998) Upregulation of Jun and Fos family members and permanent JNK activity lead to constitutive AP-1 activation in Theileria-transformed leukocytes. Mol Biochem Parasitol 94:215-226
4. Guergnon J, Dessauge F, Langsley G, Garcia A (2003) Apoptosis of Theileria-infected lymphocytes induced upon parasite death involves activation of caspases 9 and 3. Biochimie 85:771-776
5. Kuenzi P, Schneider P, Dobbelaere DA (2003) Theileria parvatransformed T cells show enhanced resistance to Fas(Fas ligand-induced apoptosis. J Immunol 171:1224-1231
6. Frisch SM (2000) cAMP takes control. Nat Cell Biol 2:E167-168
7. Scott JD (1991) Cyclic nucleotide-dependent protein kinases. Pharmacol Ther 50:123-145
8. Taylor SS et al (1988) CAMP-dependent protein kinase: prototype for a family of enzymes. Faseb J 2:2677-2685
9. Lizcano JM, Morrice N, Cohen P (2000) Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem J 349:547-557
10. Harada H et al (1999) Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol Cell 3:413-422
11. Baumgartner M, Chaussepied M, Moreau MF, Werling D, Davis WC, Garcia A, Langsley G (2000) Constitutive PI3-K activity is essential for proliferation, but not survival, of Theileria parva-transformed B cells. Cell Microbiol 2:329-339
12. Scott JD, Fischer EH, Takio K, Demaille JG, Krebs EG (1985) Amino acid sequence of the heat-stable inhibitor of the cAMP-dependent protein kinase from rabbit skeletal muscle. Proc Natl Acad Sci USA 82:5732-5736
13. Scott JD, Fischer EH, Demaille JG, Krebs EG (1985) Identification of an inhibitory region of the heat-stable protein inhibitor of the cAMP-dependent protein kinase. Proc Natl Acad Sci USA 82:4379-4383
14. Guergnon J, Dessauge F, Dominguez V et al (2006) Use of penetrating eptides interacting with PP1 (PP2A proteins as a basis for a new Drug Phosphatase Technology. Mol Pharmacol 69:1115-1124
15. Moreau MF et al (1999) Theileria annulata in CD5(+) macrophages and B1 B cells. Infect Immun 67:6678-6682
16. Vindelov LL (1977) Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei. Virchows Arch B Cell Pathol 24:227-242
17. Roskoski R Jr. (1983) Assays of protein kinase. Methods Enzymol 99:3-6.
18. Scott JD, Glaccum MB, Fischer EH, Krebs EG (1986) Primary-structure requirements for inhibition by the heat-stable inhibitor of the cAMP-dependent protein kinase. Proc Natl Acad Sci USA 83:1613-1616
19. Syin C, Parzy D, Traincard F et al (2001) The H89 cAMP-dependent protein kinase inhibitor blocks Plasmodium falciparum development in infected erythrocytes. Eur J Biochem 268:4842-4849
20. Yang J, Liu X, Bhalla K et al (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-1132
21. Cazzolli R, Carpenter L, Biden TJ, Schmitz-Peiffer C (2001) A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate. Diabetes 50:2210-2218
22. Resjo S et al (2002) Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes. Cell Signal 14:231-238
23. Zhou XM, Liu Y, Payne G, Lutz RJ, Chittenden T (2000) Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser 155. J Biol Chem 275:25046-25051
24. Alessi DR, Andjelkovic M, Caudwell B et al (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15(23):6541-6551
25. Andjelkovic M, Jakubowicz T, Cron P, Ming XF, Han JW, Hemmings BA (1996) Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK(PKB) promoted by serum and protein phosphatase inhibitors. Proc Natl Acad Sci USA 93:5699-5704
26. Pastorino JG, Tafani M, Farber JL (1999) Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositide-3-OH kinase-dependent pathway. J Biol Chem 274:19411-19416
27. Cardone L et al (2002) A-kinase anchor protein 84(121 are targeted to mitochondria and mitotic spindles by overlapping amino-terminal motifs. J Mol Biol 320:663-667
28. Affaitati A et al (2003) Essential role of A-kinase anchor protein 121 for cAMP signaling to mitochondria. J Biol Chem 278:4286-4294
29. Wu KJ, Mattioli M, Morse HC, 3rd Dalla-Favera R (2002) c-MYC activates protein kinase A (PKA) by direct transcriptional activation of the PKA catalytic subunit beta (PKA-Cbeta) gene. Oncogene 21:7872-7882
30. Dessauge F, Hilaly S, Baumgartner M, Blumen B, Werling D, Langsley G (2005) c-Myc activation by Theileria parasites promotes survival of infected B-lymphocytes. Oncogene 24:1075-1083
31. Dobbelaere DA, Prospero TD, Roditi IJ et al (1990) Expression of Tac antigen component of bovine interleukin-2 receptor in different leukocyte populations infected with Theileria parva or Theileria annulate. Infect Immun 58:3847-3855
32. Ruth P, Kamm S, Nau U, Pfeifer A, Hofmann FA (1996) cGMP kinase mutant with increased sensitivity to the protein kinase inhibitor peptide PKI(5-24). Biol Chem 377:513-520
33. Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105
34. Wyllie AH (1997) Apoptosis and carcinogenesis. Eur J Cell Biol 73:189-197
35. Farrow B et al (2003) Inhibition of pancreatic cancer cell growth and induction of apoptosis with novel therapies directed against protein kinase A. Surgery 134:197-205
36. Lyons SK, Clarke AR (1997) Apoptosis and carcinogenesis. Br Med Bull 53:554-569
37. Tortora G, Ciardiello F (2002) Protein kinase A as target for novel integrated strategies of cancer therapy. Ann NY Acad Sci 968:139-147